Jenga Biosciences

Curated by Signal

Developer of cancer treatments for veterinary use

Overview

Developer of cancer treatments for veterinary use. The company is pioneering immunotherapies which include JEN-101, a therapy in the battle against canine oral melanoma and possibly other solid tumors.

Key facts

Founded: 2024
Headquarters: Carmel, United States
Stage: Sign up to view
Industry: Health Technology

Business model

2 products and services: Sign up to view

Contact

Primary office: Sign up to view
Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Collective Thinking
Provider of clinical decision support platform to manage revenue cycles
Health TechnologyParis, United States
Immunetrics
Predictive computer models based on biological responses towards diseases and intervention
Health TechnologyPittsburgh, United States
Penn Health Group
Cultivator and producer of cannabis products
Health TechnologyUnited States

About Jenga Biosciences

What does Jenga Biosciences do?

Developer of cancer treatments for veterinary use.

Where is Jenga Biosciences headquartered?

Jenga Biosciences is headquartered in Carmel, United States.

When was Jenga Biosciences founded?

Jenga Biosciences was founded in 2024.

Which sector is Jenga Biosciences in?

Jenga Biosciences operates in Health Technology.

Who are Jenga Biosciences's competitors?

Companies similar to Jenga Biosciences include Collective Thinking, Immunetrics, and Penn Health Group.